Preclinical and clinical studies have established MUC5AC’s role in conferring aggressive features to pancreatic cancer cells, including viability, anchorage-independent growth, motility, adhesion, angiogenesis, invasion, metastasis, and chemoresistance (35, 42–47). This evidence concerns the gene MUC5AC and familial pancreatic carcinoma.